

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 4.88349911 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.88349911 |
| 3 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.87660640 |
| 4 | cholesterol efflux (GO:0033344) | 4.59937641 |
| 5 | plasma lipoprotein particle clearance (GO:0034381) | 4.59814899 |
| 6 | plasma lipoprotein particle assembly (GO:0034377) | 4.56395129 |
| 7 | regulation of apoptotic cell clearance (GO:2000425) | 4.48581954 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 4.43576964 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.43576964 |
| 10 | negative regulation of protein activation cascade (GO:2000258) | 4.34500016 |
| 11 | protein-lipid complex assembly (GO:0065005) | 4.13566545 |
| 12 | negative regulation of sterol transport (GO:0032372) | 4.12101193 |
| 13 | negative regulation of cholesterol transport (GO:0032375) | 4.12101193 |
| 14 | plasma lipoprotein particle organization (GO:0071827) | 4.02480162 |
| 15 | aromatic amino acid family catabolic process (GO:0009074) | 4.01202811 |
| 16 | phospholipid efflux (GO:0033700) | 3.95023567 |
| 17 | negative regulation of complement activation (GO:0045916) | 3.92351115 |
| 18 | regulation of macrophage chemotaxis (GO:0010758) | 3.91167080 |
| 19 | ethanol oxidation (GO:0006069) | 3.90811692 |
| 20 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.89693746 |
| 21 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.89693746 |
| 22 | fibrinolysis (GO:0042730) | 3.88752257 |
| 23 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.83598753 |
| 24 | protein-lipid complex subunit organization (GO:0071825) | 3.82386690 |
| 25 | low-density lipoprotein particle clearance (GO:0034383) | 3.76721340 |
| 26 | protein activation cascade (GO:0072376) | 3.70790041 |
| 27 | fatty acid elongation (GO:0030497) | 3.69645526 |
| 28 | reverse cholesterol transport (GO:0043691) | 3.66161689 |
| 29 | coenzyme catabolic process (GO:0009109) | 3.63122050 |
| 30 | intestinal cholesterol absorption (GO:0030299) | 3.62057398 |
| 31 | acute-phase response (GO:0006953) | 3.61455696 |
| 32 | complement activation, classical pathway (GO:0006958) | 3.60273034 |
| 33 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.57028434 |
| 34 | bile acid biosynthetic process (GO:0006699) | 3.54121627 |
| 35 | complement activation (GO:0006956) | 3.53848056 |
| 36 | regulation of cholesterol storage (GO:0010885) | 3.51526096 |
| 37 | negative regulation of blood coagulation (GO:0030195) | 3.47089710 |
| 38 | negative regulation of hemostasis (GO:1900047) | 3.47089710 |
| 39 | lipoprotein metabolic process (GO:0042157) | 3.41748917 |
| 40 | positive regulation of extracellular matrix organization (GO:1903055) | 3.37577694 |
| 41 | positive regulation of blood coagulation (GO:0030194) | 3.37483698 |
| 42 | positive regulation of hemostasis (GO:1900048) | 3.37483698 |
| 43 | negative regulation of coagulation (GO:0050819) | 3.36574136 |
| 44 | cellular ketone body metabolic process (GO:0046950) | 3.33530756 |
| 45 | alpha-linolenic acid metabolic process (GO:0036109) | 3.31319577 |
| 46 | regulation of humoral immune response (GO:0002920) | 3.28997097 |
| 47 | tryptophan catabolic process (GO:0006569) | 3.27457654 |
| 48 | indole-containing compound catabolic process (GO:0042436) | 3.27457654 |
| 49 | indolalkylamine catabolic process (GO:0046218) | 3.27457654 |
| 50 | neuron cell-cell adhesion (GO:0007158) | 3.26779924 |
| 51 | epoxygenase P450 pathway (GO:0019373) | 3.26432424 |
| 52 | negative regulation of humoral immune response (GO:0002921) | 3.25706366 |
| 53 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.24511123 |
| 54 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.21620877 |
| 55 | positive regulation of coagulation (GO:0050820) | 3.21402950 |
| 56 | sterol transport (GO:0015918) | 3.18249807 |
| 57 | cholesterol transport (GO:0030301) | 3.18249807 |
| 58 | ethanol metabolic process (GO:0006067) | 3.15694124 |
| 59 | presynaptic membrane assembly (GO:0097105) | 3.15611945 |
| 60 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.13408398 |
| 61 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.13278685 |
| 62 | synaptic vesicle exocytosis (GO:0016079) | 3.13194585 |
| 63 | gamma-aminobutyric acid transport (GO:0015812) | 3.11163027 |
| 64 | oligosaccharide catabolic process (GO:0009313) | 3.09939069 |
| 65 | kynurenine metabolic process (GO:0070189) | 3.05962866 |
| 66 | very long-chain fatty acid metabolic process (GO:0000038) | 3.04974706 |
| 67 | regulation of plasminogen activation (GO:0010755) | 3.04382790 |
| 68 | tryptophan metabolic process (GO:0006568) | 3.04329465 |
| 69 | glutamate metabolic process (GO:0006536) | 3.04311180 |
| 70 | detection of molecule of bacterial origin (GO:0032490) | 3.03333652 |
| 71 | dopamine transport (GO:0015872) | 3.03015816 |
| 72 | succinate metabolic process (GO:0006105) | 3.02485154 |
| 73 | cofactor catabolic process (GO:0051187) | 3.01029672 |
| 74 | tyrosine metabolic process (GO:0006570) | 3.00327154 |
| 75 | triglyceride homeostasis (GO:0070328) | 3.00019155 |
| 76 | acylglycerol homeostasis (GO:0055090) | 3.00019155 |
| 77 | intestinal absorption (GO:0050892) | 2.99668711 |
| 78 | presynaptic membrane organization (GO:0097090) | 2.98984989 |
| 79 | dicarboxylic acid catabolic process (GO:0043649) | 2.96275106 |
| 80 | vocalization behavior (GO:0071625) | 2.96190273 |
| 81 | regulation of mononuclear cell migration (GO:0071675) | 2.95598354 |
| 82 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.93577454 |
| 83 | negative regulation of wound healing (GO:0061045) | 2.92759062 |
| 84 | exogenous drug catabolic process (GO:0042738) | 2.92176170 |
| 85 | bile acid metabolic process (GO:0008206) | 2.91225140 |
| 86 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.90391622 |
| 87 | complement activation, alternative pathway (GO:0006957) | 2.89102596 |
| 88 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.88042911 |
| 89 | neuronal action potential propagation (GO:0019227) | 2.87865807 |
| 90 | acute inflammatory response (GO:0002526) | 2.87744758 |
| 91 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.86640193 |
| 92 | ketone body metabolic process (GO:1902224) | 2.86617500 |
| 93 | aromatic amino acid family metabolic process (GO:0009072) | 2.86385603 |
| 94 | glyoxylate metabolic process (GO:0046487) | 2.86219553 |
| 95 | sulfur amino acid catabolic process (GO:0000098) | 2.85266832 |
| 96 | positive regulation of chemokine secretion (GO:0090197) | 2.85013240 |
| 97 | glycosphingolipid catabolic process (GO:0046479) | 2.85009690 |
| 98 | cholesterol homeostasis (GO:0042632) | 2.84517555 |
| 99 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.84094615 |
| 100 | phospholipid homeostasis (GO:0055091) | 2.81881970 |
| 101 | drug catabolic process (GO:0042737) | 2.81548875 |
| 102 | high-density lipoprotein particle remodeling (GO:0034375) | 2.81511017 |
| 103 | aldehyde catabolic process (GO:0046185) | 2.79907195 |
| 104 | glutamate receptor signaling pathway (GO:0007215) | 2.79454830 |
| 105 | sterol homeostasis (GO:0055092) | 2.79400115 |
| 106 | urea cycle (GO:0000050) | 2.78914500 |
| 107 | urea metabolic process (GO:0019627) | 2.78914500 |
| 108 | blood coagulation, intrinsic pathway (GO:0007597) | 2.78172632 |
| 109 | cellular glucuronidation (GO:0052695) | 2.77187184 |
| 110 | omega-hydroxylase P450 pathway (GO:0097267) | 2.76135472 |
| 111 | regulation of cholesterol homeostasis (GO:2000188) | 2.75697296 |
| 112 | lipoprotein transport (GO:0042953) | 2.75615201 |
| 113 | alpha-amino acid catabolic process (GO:1901606) | 2.75324978 |
| 114 | cysteine metabolic process (GO:0006534) | 2.74930630 |
| 115 | negative regulation of neurotransmitter transport (GO:0051589) | 2.74889098 |
| 116 | positive regulation of lipid storage (GO:0010884) | 2.74451322 |
| 117 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.74122688 |
| 118 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.74085231 |
| 119 | positive regulation of phagocytosis (GO:0050766) | 2.73432852 |
| 120 | opsonization (GO:0008228) | 2.72597031 |
| 121 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.71336852 |
| 122 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.71322177 |
| 123 | positive regulation of steroid metabolic process (GO:0045940) | 2.70716120 |
| 124 | uronic acid metabolic process (GO:0006063) | 2.70259003 |
| 125 | glucuronate metabolic process (GO:0019585) | 2.70259003 |
| 126 | regulation of acute inflammatory response (GO:0002673) | 2.69836009 |
| 127 | diacylglycerol metabolic process (GO:0046339) | 2.68942889 |
| 128 | regulation of fibrinolysis (GO:0051917) | 2.67817419 |
| 129 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.67060544 |
| 130 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.66299164 |
| 131 | regulation of protein activation cascade (GO:2000257) | 2.65851136 |
| 132 | cellular amino acid catabolic process (GO:0009063) | 2.65795595 |
| 133 | regulation of triglyceride catabolic process (GO:0010896) | 2.65683430 |
| 134 | regulation of glutamate secretion (GO:0014048) | 2.65285894 |
| 135 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.65220968 |
| 136 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.65039288 |
| 137 | angiotensin maturation (GO:0002003) | 2.64904034 |
| 138 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.64073498 |
| 139 | short-chain fatty acid metabolic process (GO:0046459) | 2.64059508 |
| 140 | low-density lipoprotein particle remodeling (GO:0034374) | 2.63865347 |
| 141 | aspartate family amino acid catabolic process (GO:0009068) | 2.63684591 |
| 142 | behavioral response to cocaine (GO:0048148) | 2.63592726 |
| 143 | acylglycerol catabolic process (GO:0046464) | 2.62957524 |
| 144 | neuron-neuron synaptic transmission (GO:0007270) | 2.62392880 |
| 145 | macromolecular complex remodeling (GO:0034367) | 2.61973358 |
| 146 | plasma lipoprotein particle remodeling (GO:0034369) | 2.61973358 |
| 147 | protein-lipid complex remodeling (GO:0034368) | 2.61973358 |
| 148 | response to histamine (GO:0034776) | 2.61792870 |
| 149 | peroxisome fission (GO:0016559) | 2.61359155 |
| 150 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.61270134 |
| 151 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.61270134 |
| 152 | acyl-CoA metabolic process (GO:0006637) | 2.60952888 |
| 153 | thioester metabolic process (GO:0035383) | 2.60952888 |
| 154 | negative regulation of fibrinolysis (GO:0051918) | 2.57502880 |
| 155 | nitrogen cycle metabolic process (GO:0071941) | 2.57495043 |
| 156 | lysine metabolic process (GO:0006553) | 2.57179127 |
| 157 | lysine catabolic process (GO:0006554) | 2.57179127 |
| 158 | glutamate secretion (GO:0014047) | 2.57060988 |
| 159 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.55984471 |
| 160 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.55940693 |
| 161 | oxaloacetate metabolic process (GO:0006107) | 2.55853279 |
| 162 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.55467548 |
| 163 | protein carboxylation (GO:0018214) | 2.55467548 |
| 164 | acyl-CoA biosynthetic process (GO:0071616) | 2.55424795 |
| 165 | thioester biosynthetic process (GO:0035384) | 2.55424795 |
| 166 | indolalkylamine metabolic process (GO:0006586) | 2.55041354 |
| 167 | neurotransmitter uptake (GO:0001504) | 2.54374776 |
| 168 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.54226011 |
| 169 | chaperone-mediated protein transport (GO:0072321) | 2.53093309 |
| 170 | regulation of cholesterol esterification (GO:0010872) | 2.52803081 |
| 171 | NADH metabolic process (GO:0006734) | 2.51110775 |
| 172 | cellular biogenic amine catabolic process (GO:0042402) | 2.50011528 |
| 173 | amine catabolic process (GO:0009310) | 2.50011528 |
| 174 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.49515680 |
| 175 | respiratory electron transport chain (GO:0022904) | 2.49274589 |
| 176 | protein localization to synapse (GO:0035418) | 2.48945086 |
| 177 | regulation of complement activation (GO:0030449) | 2.48524496 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.02632068 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.90081411 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.59722449 |
| 4 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.57049599 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.47144454 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.75474608 |
| 7 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.69609609 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.56219325 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.51227299 |
| 10 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.45163812 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.40405094 |
| 12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.38555069 |
| 13 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.32075630 |
| 14 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.31208075 |
| 15 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.27580617 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.26446944 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.26343385 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.24457432 |
| 19 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.16115905 |
| 20 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.14146336 |
| 21 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.10253879 |
| 22 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.09102645 |
| 23 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.08837433 |
| 24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.06464391 |
| 25 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.03595494 |
| 26 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.02156451 |
| 27 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.94236980 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.94170805 |
| 29 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.92030141 |
| 30 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.90807896 |
| 31 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.86663393 |
| 32 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.84229798 |
| 33 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.83977800 |
| 34 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.83714331 |
| 35 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.82533784 |
| 36 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.81184332 |
| 37 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.77028261 |
| 38 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.75168306 |
| 39 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.75168306 |
| 40 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.75003396 |
| 41 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.73537434 |
| 42 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.71241503 |
| 43 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.66358541 |
| 44 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.64194263 |
| 45 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.63590053 |
| 46 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.61929912 |
| 47 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.61774262 |
| 48 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.60205743 |
| 49 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.59901729 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.59337322 |
| 51 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.58034403 |
| 52 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.58020529 |
| 53 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.57498000 |
| 54 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.56996895 |
| 55 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.55784462 |
| 56 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.54816434 |
| 57 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.54658533 |
| 58 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.54595848 |
| 59 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.52040655 |
| 60 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.46884180 |
| 61 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.46566775 |
| 62 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.46461292 |
| 63 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.44847232 |
| 64 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.43887612 |
| 65 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.43551950 |
| 66 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.43304983 |
| 67 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.40222283 |
| 68 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.40172713 |
| 69 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.39838646 |
| 70 | VDR_22108803_ChIP-Seq_LS180_Human | 1.38841522 |
| 71 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.38812822 |
| 72 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.38541722 |
| 73 | FUS_26573619_Chip-Seq_HEK293_Human | 1.36822970 |
| 74 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.36533762 |
| 75 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.36200466 |
| 76 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.35634166 |
| 77 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.34847608 |
| 78 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.34642717 |
| 79 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.34595098 |
| 80 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.33679895 |
| 81 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.33221039 |
| 82 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.31794357 |
| 83 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.31671560 |
| 84 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.31057885 |
| 85 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.29442475 |
| 86 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.29442475 |
| 87 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.28821881 |
| 88 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.28632455 |
| 89 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.28171594 |
| 90 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.27567464 |
| 91 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.26996374 |
| 92 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25361619 |
| 93 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.25028634 |
| 94 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.23975765 |
| 95 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.23821389 |
| 96 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.22739832 |
| 97 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21453749 |
| 98 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.19896335 |
| 99 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.19837518 |
| 100 | GATA1_22025678_ChIP-Seq_K562_Human | 1.19092958 |
| 101 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.18863375 |
| 102 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.18141851 |
| 103 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17556838 |
| 104 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.16882055 |
| 105 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16347533 |
| 106 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.16305366 |
| 107 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.13434651 |
| 108 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.13397627 |
| 109 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.12268085 |
| 110 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11574238 |
| 111 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.11464280 |
| 112 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.11392430 |
| 113 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.10793179 |
| 114 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.10485503 |
| 115 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.09920718 |
| 116 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08171293 |
| 117 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.06180813 |
| 118 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.06047569 |
| 119 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05358652 |
| 120 | SPI1_23127762_ChIP-Seq_K562_Human | 1.04926037 |
| 121 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.04673516 |
| 122 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.04271463 |
| 123 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04012247 |
| 124 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.02911382 |
| 125 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02463425 |
| 126 | JUN_21703547_ChIP-Seq_K562_Human | 1.02244264 |
| 127 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.02141500 |
| 128 | STAT3_23295773_ChIP-Seq_U87_Human | 1.01443705 |
| 129 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.01396185 |
| 130 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01201809 |
| 131 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.99637282 |
| 132 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.99632864 |
| 133 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99447098 |
| 134 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.98471035 |
| 135 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.98471035 |
| 136 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.97677788 |
| 137 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.96609552 |
| 138 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.95900131 |
| 139 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.95805421 |
| 140 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.94423403 |
| 141 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94096021 |
| 142 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.93849466 |
| 143 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.93074056 |
| 144 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.92884827 |
| 145 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.92751336 |
| 146 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.92168777 |
| 147 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.90903635 |
| 148 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.90820709 |
| 149 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90346926 |
| 150 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.90081619 |
| 151 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.89764737 |
| 152 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.89394892 |
| 153 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.89340704 |
| 154 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.89301524 |
| 155 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.88919195 |
| 156 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88410835 |
| 157 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.86977257 |
| 158 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.84957998 |
| 159 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.84457524 |
| 160 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83432030 |
| 161 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.82749349 |
| 162 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82521600 |
| 163 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.82348498 |
| 164 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.82326185 |
| 165 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.82038304 |
| 166 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81533254 |
| 167 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.80600557 |
| 168 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80546450 |
| 169 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80199615 |
| 170 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.78404283 |
| 171 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.78060651 |
| 172 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.76695853 |
| 173 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.75055061 |
| 174 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.73748718 |
| 175 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.73433445 |
| 176 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.72585047 |
| 177 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72107487 |
| 178 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.72067201 |
| 179 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.71557956 |
| 180 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.70981047 |
| 181 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.70577103 |
| 182 | TP53_16413492_ChIP-PET_HCT116_Human | 0.70003258 |
| 183 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.69620727 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.52340301 |
| 2 | MP0003880_abnormal_central_pattern | 4.21503141 |
| 3 | MP0005360_urolithiasis | 3.93166075 |
| 4 | MP0008875_abnormal_xenobiotic_pharmacok | 3.55777290 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.45093434 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.37747460 |
| 7 | MP0005365_abnormal_bile_salt | 3.23167447 |
| 8 | MP0004859_abnormal_synaptic_plasticity | 2.92362687 |
| 9 | MP0002736_abnormal_nociception_after | 2.71894735 |
| 10 | MP0003635_abnormal_synaptic_transmissio | 2.51894865 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.50653017 |
| 12 | MP0009745_abnormal_behavioral_response | 2.42351406 |
| 13 | MP0002064_seizures | 2.32710375 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.27225914 |
| 15 | MP0003172_abnormal_lysosome_physiology | 2.26542371 |
| 16 | MP0006082_CNS_inflammation | 2.19967507 |
| 17 | MP0010329_abnormal_lipoprotein_level | 2.15065283 |
| 18 | MP0005167_abnormal_blood-brain_barrier | 2.14435715 |
| 19 | MP0002837_dystrophic_cardiac_calcinosis | 2.14103708 |
| 20 | MP0002063_abnormal_learning/memory/cond | 2.06151175 |
| 21 | MP0001501_abnormal_sleep_pattern | 2.05272784 |
| 22 | MP0002822_catalepsy | 2.03646076 |
| 23 | MP0006054_spinal_hemorrhage | 2.01249190 |
| 24 | MP0004270_analgesia | 2.00196231 |
| 25 | MP0003303_peritoneal_inflammation | 1.98257094 |
| 26 | MP0002572_abnormal_emotion/affect_behav | 1.98143952 |
| 27 | MP0009046_muscle_twitch | 1.95930540 |
| 28 | MP0001529_abnormal_vocalization | 1.95392951 |
| 29 | MP0002272_abnormal_nervous_system | 1.94789749 |
| 30 | MP0003329_amyloid_beta_deposits | 1.90413049 |
| 31 | MP0003195_calcinosis | 1.87379842 |
| 32 | MP0009785_altered_susceptibility_to | 1.86046134 |
| 33 | MP0006276_abnormal_autonomic_nervous | 1.83983534 |
| 34 | MP0002876_abnormal_thyroid_physiology | 1.81982269 |
| 35 | MP0001440_abnormal_grooming_behavior | 1.79804963 |
| 36 | MP0003436_decreased_susceptibility_to | 1.76719409 |
| 37 | MP0002138_abnormal_hepatobiliary_system | 1.76029209 |
| 38 | MP0001486_abnormal_startle_reflex | 1.72807355 |
| 39 | MP0005332_abnormal_amino_acid | 1.72059157 |
| 40 | MP0001905_abnormal_dopamine_level | 1.70998043 |
| 41 | MP0004142_abnormal_muscle_tone | 1.70468933 |
| 42 | MP0002419_abnormal_innate_immunity | 1.66909733 |
| 43 | MP0002733_abnormal_thermal_nociception | 1.60892528 |
| 44 | MP0005408_hypopigmentation | 1.59649985 |
| 45 | MP0005670_abnormal_white_adipose | 1.58570836 |
| 46 | MP0002148_abnormal_hypersensitivity_rea | 1.54640414 |
| 47 | MP0005535_abnormal_body_temperature | 1.53318621 |
| 48 | MP0005646_abnormal_pituitary_gland | 1.53192823 |
| 49 | MP0000604_amyloidosis | 1.52065010 |
| 50 | MP0005464_abnormal_platelet_physiology | 1.50362042 |
| 51 | MP0002735_abnormal_chemical_nociception | 1.49687607 |
| 52 | MP0003300_gastrointestinal_ulcer | 1.49605273 |
| 53 | MP0000343_altered_response_to | 1.49040492 |
| 54 | MP0005083_abnormal_biliary_tract | 1.48780516 |
| 55 | MP0005164_abnormal_response_to | 1.46125439 |
| 56 | MP0002067_abnormal_sensory_capabilities | 1.44690441 |
| 57 | MP0001970_abnormal_pain_threshold | 1.44399557 |
| 58 | MP0002118_abnormal_lipid_homeostasis | 1.40413669 |
| 59 | MP0003252_abnormal_bile_duct | 1.38606748 |
| 60 | MP0001533_abnormal_skeleton_physiology | 1.38014539 |
| 61 | MP0003690_abnormal_glial_cell | 1.37143200 |
| 62 | MP0003191_abnormal_cellular_cholesterol | 1.36756987 |
| 63 | MP0005025_abnormal_response_to | 1.36100520 |
| 64 | MP0008469_abnormal_protein_level | 1.35948754 |
| 65 | MP0002734_abnormal_mechanical_nocicepti | 1.34996212 |
| 66 | MP0009764_decreased_sensitivity_to | 1.34736439 |
| 67 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.32439210 |
| 68 | MP0000920_abnormal_myelination | 1.31317515 |
| 69 | MP0004883_abnormal_blood_vessel | 1.29821893 |
| 70 | MP0005386_behavior/neurological_phenoty | 1.27289190 |
| 71 | MP0004924_abnormal_behavior | 1.27289190 |
| 72 | MP0002998_abnormal_bone_remodeling | 1.26422090 |
| 73 | MP0001835_abnormal_antigen_presentation | 1.24860218 |
| 74 | MP0003868_abnormal_feces_composition | 1.23704634 |
| 75 | MP0001666_abnormal_nutrient_absorption | 1.23363285 |
| 76 | MP0006036_abnormal_mitochondrial_physio | 1.21955139 |
| 77 | MP0005387_immune_system_phenotype | 1.20209130 |
| 78 | MP0001790_abnormal_immune_system | 1.20209130 |
| 79 | MP0008874_decreased_physiological_sensi | 1.17269731 |
| 80 | MP0000685_abnormal_immune_system | 1.16865773 |
| 81 | MP0001764_abnormal_homeostasis | 1.16397368 |
| 82 | MP0003633_abnormal_nervous_system | 1.15002448 |
| 83 | MP0002971_abnormal_brown_adipose | 1.14941498 |
| 84 | MP0009697_abnormal_copulation | 1.14806043 |
| 85 | MP0003950_abnormal_plasma_membrane | 1.13741241 |
| 86 | MP0001845_abnormal_inflammatory_respons | 1.07702682 |
| 87 | MP0003011_delayed_dark_adaptation | 1.07038930 |
| 88 | MP0009115_abnormal_fat_cell | 1.06395220 |
| 89 | MP0005166_decreased_susceptibility_to | 1.04182179 |
| 90 | MP0008872_abnormal_physiological_respon | 1.04102070 |
| 91 | MP0002132_abnormal_respiratory_system | 1.03528495 |
| 92 | MP0003631_nervous_system_phenotype | 1.02280817 |
| 93 | MP0001853_heart_inflammation | 1.01323211 |
| 94 | MP0004130_abnormal_muscle_cell | 1.00256323 |
| 95 | MP0009643_abnormal_urine_homeostasis | 0.99072753 |
| 96 | MP0003879_abnormal_hair_cell | 0.99064510 |
| 97 | MP0004043_abnormal_pH_regulation | 0.97403563 |
| 98 | MP0005171_absent_coat_pigmentation | 0.97258127 |
| 99 | MP0010368_abnormal_lymphatic_system | 0.96298867 |
| 100 | MP0002066_abnormal_motor_capabilities/c | 0.96285067 |
| 101 | MP0000249_abnormal_blood_vessel | 0.94814904 |
| 102 | MP0005423_abnormal_somatic_nervous | 0.94768748 |
| 103 | MP0001756_abnormal_urination | 0.94523684 |
| 104 | MP0004885_abnormal_endolymph | 0.93961570 |
| 105 | MP0003656_abnormal_erythrocyte_physiolo | 0.93551831 |
| 106 | MP0005000_abnormal_immune_tolerance | 0.93255069 |
| 107 | MP0009780_abnormal_chondrocyte_physiolo | 0.92828986 |
| 108 | MP0002557_abnormal_social/conspecific_i | 0.92424617 |
| 109 | MP0004147_increased_porphyrin_level | 0.92148588 |
| 110 | MP0000858_altered_metastatic_potential | 0.92138477 |
| 111 | MP0005257_abnormal_intraocular_pressure | 0.91403607 |
| 112 | MP0002933_joint_inflammation | 0.90503846 |
| 113 | MP0000013_abnormal_adipose_tissue | 0.89500097 |
| 114 | MP0003122_maternal_imprinting | 0.88968757 |
| 115 | MP0000371_diluted_coat_color | 0.88951476 |
| 116 | MP0002229_neurodegeneration | 0.88475328 |
| 117 | MP0009840_abnormal_foam_cell | 0.88458086 |
| 118 | MP0001915_intracranial_hemorrhage | 0.87914360 |
| 119 | MP0009763_increased_sensitivity_to | 0.87236615 |
| 120 | MP0003136_yellow_coat_color | 0.86348896 |
| 121 | MP0003828_pulmonary_edema | 0.85686984 |
| 122 | MP0002909_abnormal_adrenal_gland | 0.84643605 |
| 123 | MP0008438_abnormal_cutaneous_collagen | 0.83317713 |
| 124 | MP0003183_abnormal_peptide_metabolism | 0.82482858 |
| 125 | MP0001664_abnormal_digestion | 0.81822992 |
| 126 | MP0002452_abnormal_antigen_presenting | 0.81654679 |
| 127 | MP0001502_abnormal_circadian_rhythm | 0.80480399 |
| 128 | MP0004019_abnormal_vitamin_homeostasis | 0.80255615 |
| 129 | MP0001661_extended_life_span | 0.79792982 |
| 130 | MP0000609_abnormal_liver_physiology | 0.78373074 |
| 131 | MP0001986_abnormal_taste_sensitivity | 0.78227610 |
| 132 | MP0002184_abnormal_innervation | 0.78141072 |
| 133 | MP0003632_abnormal_nervous_system | 0.76947152 |
| 134 | MP0005023_abnormal_wound_healing | 0.76909499 |
| 135 | MP0002405_respiratory_system_inflammati | 0.76753832 |
| 136 | MP0005671_abnormal_response_to | 0.76406163 |
| 137 | MP0005319_abnormal_enzyme/_coenzyme | 0.76088110 |
| 138 | MP0003075_altered_response_to | 0.76024040 |
| 139 | MP0001984_abnormal_olfaction | 0.75912594 |
| 140 | MP0005165_increased_susceptibility_to | 0.75499912 |
| 141 | MP0002332_abnormal_exercise_endurance | 0.75368352 |
| 142 | MP0003186_abnormal_redox_activity | 0.75015433 |
| 143 | MP0008569_lethality_at_weaning | 0.74787214 |
| 144 | MP0002723_abnormal_immune_serum | 0.74759272 |
| 145 | MP0000639_abnormal_adrenal_gland | 0.74144875 |
| 146 | MP0005647_abnormal_sex_gland | 0.73892399 |
| 147 | MP0010386_abnormal_urinary_bladder | 0.73804394 |
| 148 | MP0005551_abnormal_eye_electrophysiolog | 0.73703732 |
| 149 | MP0010155_abnormal_intestine_physiology | 0.73189180 |
| 150 | MP0000778_abnormal_nervous_system | 0.72702476 |
| 151 | MP0003724_increased_susceptibility_to | 0.72689948 |
| 152 | MP0006035_abnormal_mitochondrial_morpho | 0.72343620 |
| 153 | MP0005376_homeostasis/metabolism_phenot | 0.72278839 |
| 154 | MP0005636_abnormal_mineral_homeostasis | 0.71585870 |
| 155 | MP0000230_abnormal_systemic_arterial | 0.70486908 |
| 156 | MP0005451_abnormal_body_composition | 0.69852723 |
| 157 | MP0005645_abnormal_hypothalamus_physiol | 0.68928331 |
| 158 | MP0002069_abnormal_eating/drinking_beha | 0.68743187 |
| 159 | MP0005084_abnormal_gallbladder_morpholo | 0.68384568 |
| 160 | MP0000598_abnormal_liver_morphology | 0.67377611 |
| 161 | MP0009642_abnormal_blood_homeostasis | 0.67364384 |
| 162 | MP0001800_abnormal_humoral_immune | 0.66405542 |
| 163 | MP0001324_abnormal_eye_pigmentation | 0.64963318 |
| 164 | MP0005334_abnormal_fat_pad | 0.64689271 |
| 165 | MP0001958_emphysema | 0.64477632 |
| 166 | MP0008004_abnormal_stomach_pH | 0.63655037 |
| 167 | MP0005397_hematopoietic_system_phenotyp | 0.63340623 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 7.23994536 |
| 2 | Glomerulonephritis (HP:0000099) | 5.99221589 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 4.96687504 |
| 4 | Focal motor seizures (HP:0011153) | 4.80750014 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 4.52699528 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.52699528 |
| 7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.52699528 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.44385488 |
| 9 | Hyperventilation (HP:0002883) | 4.43353163 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.30864785 |
| 11 | Vacuolated lymphocytes (HP:0001922) | 3.90938881 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 3.58632087 |
| 13 | Deep venous thrombosis (HP:0002625) | 3.57032471 |
| 14 | Purpura (HP:0000979) | 3.56712895 |
| 15 | Joint hemorrhage (HP:0005261) | 3.52046864 |
| 16 | Nephritis (HP:0000123) | 3.51423623 |
| 17 | Myocardial infarction (HP:0001658) | 3.48243005 |
| 18 | Intrahepatic cholestasis (HP:0001406) | 3.47790869 |
| 19 | Dysostosis multiplex (HP:0000943) | 3.34227358 |
| 20 | Acute encephalopathy (HP:0006846) | 3.28536161 |
| 21 | Hyperlipoproteinemia (HP:0010980) | 3.25792199 |
| 22 | Acute necrotizing encephalopathy (HP:0006965) | 3.17445340 |
| 23 | Atonic seizures (HP:0010819) | 3.17405049 |
| 24 | Cerebral edema (HP:0002181) | 3.16434522 |
| 25 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.14272032 |
| 26 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.14272032 |
| 27 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.14272032 |
| 28 | Myokymia (HP:0002411) | 3.13001900 |
| 29 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.09073535 |
| 30 | Mucopolysacchariduria (HP:0008155) | 3.09073535 |
| 31 | Hypercholesterolemia (HP:0003124) | 3.07388327 |
| 32 | Epileptic encephalopathy (HP:0200134) | 3.06127254 |
| 33 | Xanthomatosis (HP:0000991) | 3.05315263 |
| 34 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.04094457 |
| 35 | Complement deficiency (HP:0004431) | 2.99880994 |
| 36 | Gingival bleeding (HP:0000225) | 2.95530088 |
| 37 | Focal seizures (HP:0007359) | 2.93680738 |
| 38 | Increased cerebral lipofuscin (HP:0011813) | 2.92364109 |
| 39 | Abnormal gallbladder physiology (HP:0012438) | 2.92148548 |
| 40 | Cholecystitis (HP:0001082) | 2.92148548 |
| 41 | Hemorrhage of the eye (HP:0011885) | 2.89777015 |
| 42 | Abnormality of macrophages (HP:0004311) | 2.85389230 |
| 43 | Mitochondrial inheritance (HP:0001427) | 2.84249491 |
| 44 | Neurofibrillary tangles (HP:0002185) | 2.84051378 |
| 45 | Progressive macrocephaly (HP:0004481) | 2.81187744 |
| 46 | Pheochromocytoma (HP:0002666) | 2.78998346 |
| 47 | Ketosis (HP:0001946) | 2.77513938 |
| 48 | Cerebral inclusion bodies (HP:0100314) | 2.77051353 |
| 49 | Neuroendocrine neoplasm (HP:0100634) | 2.71707229 |
| 50 | Cerebral hemorrhage (HP:0001342) | 2.71050846 |
| 51 | Hepatocellular necrosis (HP:0001404) | 2.70732917 |
| 52 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.67633731 |
| 53 | Hyperammonemia (HP:0001987) | 2.59560400 |
| 54 | Absence seizures (HP:0002121) | 2.59430790 |
| 55 | Hyperglycinemia (HP:0002154) | 2.59267699 |
| 56 | Vascular calcification (HP:0004934) | 2.58435845 |
| 57 | Abnormality of the intrinsic pathway (HP:0010989) | 2.57899943 |
| 58 | Mitral stenosis (HP:0001718) | 2.53841863 |
| 59 | Generalized tonic-clonic seizures (HP:0002069) | 2.52949680 |
| 60 | Dialeptic seizures (HP:0011146) | 2.52606203 |
| 61 | Eczematoid dermatitis (HP:0000976) | 2.52409550 |
| 62 | Hypothermia (HP:0002045) | 2.51813967 |
| 63 | Hepatic necrosis (HP:0002605) | 2.51239592 |
| 64 | Disinhibition (HP:0000734) | 2.49662857 |
| 65 | Lethargy (HP:0001254) | 2.48042744 |
| 66 | Skin nodule (HP:0200036) | 2.47856895 |
| 67 | Loss of speech (HP:0002371) | 2.47167859 |
| 68 | Orchitis (HP:0100796) | 2.44657672 |
| 69 | Increased CSF lactate (HP:0002490) | 2.44428997 |
| 70 | Abnormality of glycine metabolism (HP:0010895) | 2.43580884 |
| 71 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.43580884 |
| 72 | Abnormality of methionine metabolism (HP:0010901) | 2.43462564 |
| 73 | Thrombophlebitis (HP:0004418) | 2.38561188 |
| 74 | Increased serum pyruvate (HP:0003542) | 2.37830428 |
| 75 | Abnormality of glycolysis (HP:0004366) | 2.37830428 |
| 76 | Recurrent abscess formation (HP:0002722) | 2.36479187 |
| 77 | Retrobulbar optic neuritis (HP:0100654) | 2.35774983 |
| 78 | Optic neuritis (HP:0100653) | 2.35774983 |
| 79 | Spontaneous abortion (HP:0005268) | 2.34051738 |
| 80 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.33881159 |
| 81 | Cardiovascular calcification (HP:0011915) | 2.33204555 |
| 82 | Hypolipoproteinemia (HP:0010981) | 2.32532908 |
| 83 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.31755699 |
| 84 | Metaphyseal irregularity (HP:0003025) | 2.30595621 |
| 85 | Renal Fanconi syndrome (HP:0001994) | 2.29900827 |
| 86 | Pulmonary embolism (HP:0002204) | 2.29550367 |
| 87 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.29548195 |
| 88 | Visual hallucinations (HP:0002367) | 2.29396275 |
| 89 | Recurrent bacterial skin infections (HP:0005406) | 2.29325881 |
| 90 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.28448201 |
| 91 | Steatorrhea (HP:0002570) | 2.26440553 |
| 92 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.23864713 |
| 93 | Febrile seizures (HP:0002373) | 2.23742268 |
| 94 | Methylmalonic acidemia (HP:0002912) | 2.23242935 |
| 95 | Potter facies (HP:0002009) | 2.21633421 |
| 96 | Facial shape deformation (HP:0011334) | 2.21633421 |
| 97 | Epidermoid cyst (HP:0200040) | 2.21141928 |
| 98 | Mutism (HP:0002300) | 2.20280202 |
| 99 | Status epilepticus (HP:0002133) | 2.19785314 |
| 100 | Sensorimotor neuropathy (HP:0007141) | 2.19275673 |
| 101 | Anxiety (HP:0000739) | 2.18507629 |
| 102 | Menorrhagia (HP:0000132) | 2.17557515 |
| 103 | Conjugated hyperbilirubinemia (HP:0002908) | 2.17234841 |
| 104 | Myositis (HP:0100614) | 2.16186029 |
| 105 | Retinal atrophy (HP:0001105) | 2.15445307 |
| 106 | Axonal loss (HP:0003447) | 2.15237112 |
| 107 | Fat malabsorption (HP:0002630) | 2.14605548 |
| 108 | Lipid accumulation in hepatocytes (HP:0006561) | 2.13789136 |
| 109 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.13294781 |
| 110 | Lactic acidosis (HP:0003128) | 2.12616781 |
| 111 | Hyperglycinuria (HP:0003108) | 2.12484825 |
| 112 | Increased serum ferritin (HP:0003281) | 2.12170297 |
| 113 | Increased intramyocellular lipid droplets (HP:0012240) | 2.11451151 |
| 114 | Ketoacidosis (HP:0001993) | 2.11425084 |
| 115 | Hypoalphalipoproteinemia (HP:0003233) | 2.09613313 |
| 116 | Abnormality of the common coagulation pathway (HP:0010990) | 2.09570567 |
| 117 | Spastic paraparesis (HP:0002313) | 2.06741315 |
| 118 | Increased muscle lipid content (HP:0009058) | 2.06680907 |
| 119 | Rickets (HP:0002748) | 2.06278044 |
| 120 | Increased hepatocellular lipid droplets (HP:0006565) | 2.05582530 |
| 121 | Amyloidosis (HP:0011034) | 2.05489431 |
| 122 | Hydroxyprolinuria (HP:0003080) | 2.04614535 |
| 123 | Abnormality of proline metabolism (HP:0010907) | 2.04614535 |
| 124 | Oligomenorrhea (HP:0000876) | 2.04529495 |
| 125 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.03997043 |
| 126 | Leukodystrophy (HP:0002415) | 2.03491390 |
| 127 | Esophageal varix (HP:0002040) | 2.03289687 |
| 128 | Generalized aminoaciduria (HP:0002909) | 2.01930592 |
| 129 | Blue irides (HP:0000635) | 2.01780064 |
| 130 | Methylmalonic aciduria (HP:0012120) | 2.00392397 |
| 131 | Abnormality of carpal bone ossification (HP:0006257) | 2.00361343 |
| 132 | Abnormal gallbladder morphology (HP:0012437) | 1.99969203 |
| 133 | Flared iliac wings (HP:0002869) | 1.99368069 |
| 134 | Vomiting (HP:0002013) | 1.97670406 |
| 135 | Ovoid vertebral bodies (HP:0003300) | 1.96951089 |
| 136 | Dysmetria (HP:0001310) | 1.96506370 |
| 137 | Progressive inability to walk (HP:0002505) | 1.95475947 |
| 138 | Metabolic acidosis (HP:0001942) | 1.95438164 |
| 139 | Abnormality of iron homeostasis (HP:0011031) | 1.93903525 |
| 140 | Cholelithiasis (HP:0001081) | 1.93898795 |
| 141 | Generalized myoclonic seizures (HP:0002123) | 1.93654032 |
| 142 | Vertebral compression fractures (HP:0002953) | 1.93632359 |
| 143 | Epistaxis (HP:0000421) | 1.92886605 |
| 144 | Neoplasm of head and neck (HP:0012288) | 1.92573312 |
| 145 | Esophageal neoplasm (HP:0100751) | 1.92573312 |
| 146 | Fair hair (HP:0002286) | 1.88426111 |
| 147 | Hepatocellular carcinoma (HP:0001402) | 1.88145825 |
| 148 | Hypophosphatemic rickets (HP:0004912) | 1.87817558 |
| 149 | Acanthocytosis (HP:0001927) | 1.87727926 |
| 150 | Poor suck (HP:0002033) | 1.87636260 |
| 151 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.87573270 |
| 152 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.86167756 |
| 153 | Dicarboxylic aciduria (HP:0003215) | 1.86167756 |
| 154 | Scanning speech (HP:0002168) | 1.86021356 |
| 155 | Joint swelling (HP:0001386) | 1.85781894 |
| 156 | Optic disc pallor (HP:0000543) | 1.85635202 |
| 157 | Abnormality of purine metabolism (HP:0004352) | 1.85490748 |
| 158 | Nausea (HP:0002018) | 1.85309260 |
| 159 | Retinal dysplasia (HP:0007973) | 1.85196573 |
| 160 | Type II lissencephaly (HP:0007260) | 1.84729367 |
| 161 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82685323 |
| 162 | Acute hepatic failure (HP:0006554) | 1.82143962 |
| 163 | Respiratory failure (HP:0002878) | 1.80912156 |
| 164 | Abnormality of complement system (HP:0005339) | 1.80832169 |
| 165 | Craniofacial dystonia (HP:0012179) | 1.78718758 |
| 166 | Widely patent fontanelles and sutures (HP:0004492) | 1.78608950 |
| 167 | Abnormality of the lumbar spine (HP:0100712) | 1.78122301 |
| 168 | Peritonitis (HP:0002586) | 1.76671744 |
| 169 | Abnormal tarsal ossification (HP:0008369) | 1.76398904 |
| 170 | Gangrene (HP:0100758) | 1.74530427 |
| 171 | Pulmonary infiltrates (HP:0002113) | 1.74191706 |
| 172 | Gastrointestinal infarctions (HP:0005244) | 1.73238828 |
| 173 | Pathologic fracture (HP:0002756) | 1.69620625 |
| 174 | Malnutrition (HP:0004395) | 1.68644760 |
| 175 | Hypertriglyceridemia (HP:0002155) | 1.68363463 |
| 176 | Beaking of vertebral bodies (HP:0004568) | 1.68356845 |
| 177 | Arthropathy (HP:0003040) | 1.67525275 |
| 178 | Gingivitis (HP:0000230) | 1.63873262 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K12 | 4.78575159 |
| 2 | CASK | 4.20527579 |
| 3 | TGFBR2 | 4.07869316 |
| 4 | EPHA4 | 3.17540845 |
| 5 | FGFR4 | 3.13513129 |
| 6 | DDR2 | 3.12218697 |
| 7 | RIPK4 | 2.94556670 |
| 8 | BLK | 2.89720902 |
| 9 | MAP2K4 | 2.87028471 |
| 10 | TYK2 | 2.83176733 |
| 11 | FGFR3 | 2.77052272 |
| 12 | NTRK3 | 2.65457866 |
| 13 | MAP2K7 | 2.62863257 |
| 14 | ACVR1B | 2.50645053 |
| 15 | MAP3K4 | 2.41008430 |
| 16 | ERN1 | 2.37868386 |
| 17 | IRAK3 | 2.24550533 |
| 18 | CDK19 | 2.19932111 |
| 19 | PIK3CA | 2.17238567 |
| 20 | RIPK1 | 2.15620676 |
| 21 | OXSR1 | 2.13724453 |
| 22 | MUSK | 2.07697339 |
| 23 | ARAF | 1.89993188 |
| 24 | DAPK2 | 1.82230585 |
| 25 | BCKDK | 1.78015838 |
| 26 | MAP3K9 | 1.71764261 |
| 27 | PLK2 | 1.67697745 |
| 28 | DAPK1 | 1.64108283 |
| 29 | GRK5 | 1.61518949 |
| 30 | CSK | 1.59902903 |
| 31 | MAP3K14 | 1.58592067 |
| 32 | MATK | 1.57043053 |
| 33 | PDGFRA | 1.55876846 |
| 34 | CSF1R | 1.54731350 |
| 35 | BMPR2 | 1.53892323 |
| 36 | MINK1 | 1.52107406 |
| 37 | STK16 | 1.44915679 |
| 38 | NEK9 | 1.44212302 |
| 39 | KSR2 | 1.42401177 |
| 40 | MAPKAPK5 | 1.42397165 |
| 41 | ERBB4 | 1.41684722 |
| 42 | MAPKAPK3 | 1.40998372 |
| 43 | STK39 | 1.39611570 |
| 44 | MAP3K6 | 1.39160041 |
| 45 | JAK1 | 1.38684412 |
| 46 | PRKAA2 | 1.34102799 |
| 47 | AKT3 | 1.31985899 |
| 48 | FGR | 1.29586835 |
| 49 | PNCK | 1.29335899 |
| 50 | PDK2 | 1.29203616 |
| 51 | TBK1 | 1.27790423 |
| 52 | MAP3K3 | 1.27670749 |
| 53 | NME1 | 1.26439491 |
| 54 | ZAP70 | 1.25678780 |
| 55 | CAMK2A | 1.23809444 |
| 56 | MYLK | 1.23325814 |
| 57 | GRK7 | 1.20949465 |
| 58 | MAP3K2 | 1.19839377 |
| 59 | MAP3K13 | 1.14905904 |
| 60 | CAMK2B | 1.14424046 |
| 61 | GRK6 | 1.14266328 |
| 62 | CDC42BPA | 1.13997230 |
| 63 | TNIK | 1.12833983 |
| 64 | EPHA3 | 1.11582453 |
| 65 | FER | 1.06012524 |
| 66 | PTK2B | 1.04973155 |
| 67 | FES | 1.02417312 |
| 68 | NTRK1 | 1.01137594 |
| 69 | PRKCG | 1.00675724 |
| 70 | TYRO3 | 0.99812033 |
| 71 | KIT | 0.96491386 |
| 72 | SGK494 | 0.95207621 |
| 73 | SGK223 | 0.95207621 |
| 74 | JAK2 | 0.94872439 |
| 75 | RAF1 | 0.94059880 |
| 76 | ADRBK2 | 0.93476179 |
| 77 | CDK5 | 0.92768460 |
| 78 | LYN | 0.88839997 |
| 79 | TAOK3 | 0.87615338 |
| 80 | MAPK13 | 0.87611397 |
| 81 | FRK | 0.85825923 |
| 82 | BRAF | 0.84359821 |
| 83 | CAMKK2 | 0.83747142 |
| 84 | PRKCE | 0.82765429 |
| 85 | CAMK1D | 0.82052060 |
| 86 | CSNK1G2 | 0.81604277 |
| 87 | NTRK2 | 0.81219154 |
| 88 | PDGFRB | 0.80687253 |
| 89 | MAPK12 | 0.79378571 |
| 90 | IKBKB | 0.79061380 |
| 91 | SGK3 | 0.78877824 |
| 92 | CDK6 | 0.78801906 |
| 93 | CAMK2G | 0.78543452 |
| 94 | LMTK2 | 0.77303740 |
| 95 | IGF1R | 0.77048086 |
| 96 | ERBB2 | 0.75269121 |
| 97 | MARK1 | 0.75134064 |
| 98 | KSR1 | 0.74499592 |
| 99 | YES1 | 0.74247245 |
| 100 | PKN1 | 0.73747990 |
| 101 | JAK3 | 0.72879997 |
| 102 | SGK2 | 0.71824711 |
| 103 | CSNK1G3 | 0.70924557 |
| 104 | LATS1 | 0.69574703 |
| 105 | IKBKE | 0.69385221 |
| 106 | CAMK2D | 0.69205685 |
| 107 | PINK1 | 0.69102879 |
| 108 | MST4 | 0.67841553 |
| 109 | FGFR2 | 0.66671838 |
| 110 | ABL2 | 0.65064295 |
| 111 | NLK | 0.64918859 |
| 112 | MAP2K3 | 0.63572067 |
| 113 | ICK | 0.63194486 |
| 114 | MST1R | 0.62184463 |
| 115 | CSNK1G1 | 0.61681225 |
| 116 | PDPK1 | 0.61509535 |
| 117 | ABL1 | 0.60322862 |
| 118 | VRK1 | 0.59101206 |
| 119 | RET | 0.57964028 |
| 120 | PAK6 | 0.57319674 |
| 121 | MAP3K11 | 0.56828691 |
| 122 | TNK2 | 0.56066223 |
| 123 | PRKCQ | 0.55231776 |
| 124 | GSK3A | 0.54124251 |
| 125 | WNK4 | 0.53496099 |
| 126 | PDK4 | 0.52728826 |
| 127 | PDK3 | 0.52728826 |
| 128 | INSRR | 0.51642127 |
| 129 | CCNB1 | 0.51387376 |
| 130 | MAP3K1 | 0.50923425 |
| 131 | PRKACA | 0.50781711 |
| 132 | MAP2K1 | 0.50581919 |
| 133 | MAP2K6 | 0.49837504 |
| 134 | MAPK11 | 0.49833105 |
| 135 | PDK1 | 0.49824303 |
| 136 | LCK | 0.48545812 |
| 137 | NME2 | 0.47848140 |
| 138 | ADRBK1 | 0.47182825 |
| 139 | IRAK4 | 0.46963062 |
| 140 | SRC | 0.46733924 |
| 141 | BCR | 0.46117622 |
| 142 | SYK | 0.45750573 |
| 143 | PIK3CG | 0.44299065 |
| 144 | PRKG2 | 0.43363815 |
| 145 | SIK3 | 0.43285001 |
| 146 | STK38L | 0.42487687 |
| 147 | MAP3K5 | 0.41684399 |
| 148 | CAMKK1 | 0.41440585 |
| 149 | MOS | 0.41440247 |
| 150 | FGFR1 | 0.41272540 |
| 151 | DYRK1A | 0.40489229 |
| 152 | WNK3 | 0.39991261 |
| 153 | TSSK6 | 0.39307472 |
| 154 | SGK1 | 0.39108972 |
| 155 | IRAK1 | 0.38125820 |
| 156 | CAMK1 | 0.38084940 |
| 157 | CHUK | 0.37929885 |
| 158 | PRKCA | 0.37449124 |
| 159 | PRKG1 | 0.37192798 |
| 160 | PRKACG | 0.36498260 |
| 161 | FYN | 0.36184196 |
| 162 | CDK8 | 0.36098772 |
| 163 | HCK | 0.34952390 |
| 164 | INSR | 0.34631928 |
| 165 | ROCK2 | 0.34531068 |
| 166 | PIM2 | 0.34269473 |
| 167 | TIE1 | 0.34215685 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.96253690 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.90737041 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.74827252 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.59770539 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.17024933 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 2.14695551 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.13811099 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.12667500 |
| 9 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.10857932 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.07211294 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.94915955 |
| 12 | Lysosome_Homo sapiens_hsa04142 | 1.93502931 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.91169482 |
| 14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.89012208 |
| 15 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.88828979 |
| 16 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.87720534 |
| 17 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.87368542 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.85721097 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.84663241 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.69964160 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.67779217 |
| 22 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.64491883 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.63857669 |
| 24 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.61002325 |
| 25 | * Histidine metabolism_Homo sapiens_hsa00340 | 1.59781537 |
| 26 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.58341028 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.57693314 |
| 28 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.57311648 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.56560622 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.50396438 |
| 31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.49937565 |
| 32 | Parkinsons disease_Homo sapiens_hsa05012 | 1.49876522 |
| 33 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.47935737 |
| 34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.45140379 |
| 35 | Alzheimers disease_Homo sapiens_hsa05010 | 1.42576432 |
| 36 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.41228618 |
| 37 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.40092459 |
| 38 | GABAergic synapse_Homo sapiens_hsa04727 | 1.38247321 |
| 39 | Mineral absorption_Homo sapiens_hsa04978 | 1.29291958 |
| 40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.28409734 |
| 41 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.26928092 |
| 42 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.21121340 |
| 43 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.20977122 |
| 44 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.20736217 |
| 45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.19500963 |
| 46 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.16879867 |
| 47 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.16429652 |
| 48 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.14150537 |
| 49 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.13379590 |
| 50 | Asthma_Homo sapiens_hsa05310 | 1.13027217 |
| 51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.10520199 |
| 52 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.08335949 |
| 53 | Morphine addiction_Homo sapiens_hsa05032 | 1.07667239 |
| 54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.07374293 |
| 55 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.06398316 |
| 56 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.05469103 |
| 57 | Leishmaniasis_Homo sapiens_hsa05140 | 1.03582869 |
| 58 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.02455397 |
| 59 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.97456353 |
| 60 | Long-term potentiation_Homo sapiens_hsa04720 | 0.97027875 |
| 61 | Bile secretion_Homo sapiens_hsa04976 | 0.96267194 |
| 62 | Salivary secretion_Homo sapiens_hsa04970 | 0.96231181 |
| 63 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.96187821 |
| 64 | Circadian entrainment_Homo sapiens_hsa04713 | 0.95311485 |
| 65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.93152762 |
| 66 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.91136818 |
| 67 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90323387 |
| 68 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.89933133 |
| 69 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.89827565 |
| 70 | Carbon metabolism_Homo sapiens_hsa01200 | 0.88975742 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.88880985 |
| 72 | Taste transduction_Homo sapiens_hsa04742 | 0.88810006 |
| 73 | Renin secretion_Homo sapiens_hsa04924 | 0.87930797 |
| 74 | Malaria_Homo sapiens_hsa05144 | 0.83369510 |
| 75 | Tuberculosis_Homo sapiens_hsa05152 | 0.83131020 |
| 76 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.82903765 |
| 77 | Olfactory transduction_Homo sapiens_hsa04740 | 0.82891303 |
| 78 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.81325089 |
| 79 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.80130154 |
| 80 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.79770207 |
| 81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78820065 |
| 82 | Allograft rejection_Homo sapiens_hsa05330 | 0.78769166 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.76649179 |
| 84 | Retinol metabolism_Homo sapiens_hsa00830 | 0.76556104 |
| 85 | Huntingtons disease_Homo sapiens_hsa05016 | 0.76530205 |
| 86 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.75978825 |
| 87 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.74420804 |
| 88 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.74006739 |
| 89 | Long-term depression_Homo sapiens_hsa04730 | 0.73727782 |
| 90 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.71131719 |
| 91 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.70266271 |
| 92 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.69324977 |
| 93 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.68820627 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65048341 |
| 95 | Cocaine addiction_Homo sapiens_hsa05030 | 0.64377444 |
| 96 | Sulfur relay system_Homo sapiens_hsa04122 | 0.63438757 |
| 97 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.63240492 |
| 98 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.62591852 |
| 99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62119947 |
| 100 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.60440680 |
| 101 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.59967706 |
| 102 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58689830 |
| 103 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.58608868 |
| 104 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.58579962 |
| 105 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.57535560 |
| 106 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56991951 |
| 107 | ABC transporters_Homo sapiens_hsa02010 | 0.55904591 |
| 108 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.55680579 |
| 109 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.54485003 |
| 110 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.54304014 |
| 111 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52677592 |
| 112 | Legionellosis_Homo sapiens_hsa05134 | 0.52076999 |
| 113 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.50946400 |
| 114 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.49350577 |
| 115 | Insulin secretion_Homo sapiens_hsa04911 | 0.49329790 |
| 116 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.49108885 |
| 117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48899798 |
| 118 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.48633876 |
| 119 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.48522638 |
| 120 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.48074046 |
| 121 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.48066155 |
| 122 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.47330491 |
| 123 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.46491787 |
| 124 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46306380 |
| 125 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44398498 |
| 126 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43733966 |
| 127 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43716508 |
| 128 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.43362085 |
| 129 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.43285435 |
| 130 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.42323807 |
| 131 | Phagosome_Homo sapiens_hsa04145 | 0.42299876 |
| 132 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.42029300 |
| 133 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.39503738 |
| 134 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38823971 |
| 135 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.38559932 |
| 136 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.38255865 |
| 137 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.37523674 |
| 138 | Prion diseases_Homo sapiens_hsa05020 | 0.37403496 |
| 139 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35946162 |
| 140 | Amoebiasis_Homo sapiens_hsa05146 | 0.34436741 |
| 141 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.33897277 |
| 142 | Salmonella infection_Homo sapiens_hsa05132 | 0.31238821 |
| 143 | Insulin resistance_Homo sapiens_hsa04931 | 0.31034785 |
| 144 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28366594 |
| 145 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.28144051 |

